ads bit

Pages

Tuesday, September 10, 2013

Hypertension-new drug-S-amlodipine



Hypertension-new drug-S-amlodipine
S-Amlodipine 2.5 mg
new drug for mild to moderate hypertension
Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
uses-treatment of mild to moderate hypertension
There was no statistically significant change in the levels of serum creatinine, SGOT, SGPT, HDL, LDL, triglyceride and total cholesterol in patients receiving Amlodipine 5 mg. The reduction in total cholesterol as well as triglyceride level in the S-Amlodipine 2.5 mg treatment group was found to be greater but it failed to show any statistically significant difference.
CONCLUSION:
S-Amlodipine 2.5 mg is found to be equivalent in its efficacy and tolerability when compared to Amlodipine 5 mg in the treatment of mild to moderate hypertension.
(S)-amlodipine treatment was associated with significantly less edema than racemic amlodipine
Ref;

Sleep Deprivation- Food Purchasing the Next Day increase



Sleep Deprivation- Food Purchasing the Next Day increase
Sleep Deprivation Increases Food Purchasing the Next Day

Sep. 5, 2013 — People who were deprived of one night's sleep purchased more calories and grams of food in a mock supermarket on the following day in a new study published in the journal Obesity, the official journal of The Obesity Society. Sleep deprivation also led to increased blood levels of ghrelin, a hormone that increases hunger, on the following morning; however, there was no correlation between individual ghrelin levels and food purchasing, suggesting that other mechanisms -- such as
impulsive decision making -- may be more responsible for increased purchasing.

Researchers in Sweden were curious as to whether sleep deprivation may impair or alter an individual's food purchasing choices based on its established tendency to impair higher-level thinking and to increase hunger.

"We hypothesized that sleep deprivation's impact on hunger and decision making would make for the 'perfect storm' with regard to shopping and food purchasing -- leaving individuals hungrier and less capable of employing self-control and higher-level decision-making processes to avoid making impulsive, calorie-driven purchases," said first author Colin Chapman, MSc, of Uppsala University.
On the morning after one night of total sleep deprivation, as well as after one night of sleep, Chapman, along with Christian Benedict, PhD, and their colleagues, gave 14 normal-weight men a fixed budget (approximately $50). The men were instructed to purchase as much as they could out of a possible 40 items, including 20 high-caloric foods and 20 low-calorie foods. The prices of the high-caloric foods were then varied to determine if total sleep deprivation affects the flexibility of food purchasing. Before
the task, participants received a standardized breakfast to minimize the effect of hunger on their purchases.

Sleep-deprived men purchased significantly more calories (+9%) and grams (+18%) of food than they did after one night of sleep. The researchers also measured blood levels of ghrelin, finding that the hormone's concentrations were higher after total sleep deprivation; however, this increase did not correlate with food purchasing behavior.

"Our finding provides a strong rationale for suggesting that patients with concerns regarding caloric intake and weight gain maintain a healthy, normal sleep schedule," said Chapman.
Follow up studies are needed to address whether these sleep deprivation-induced changes in food purchasing behavior also exist under partial sleep deprivation, though.
Additional research should also look into sleep deprivation's potential impact on purchasing behavior in general, as it may lead to impaired or impulsive purchasing in a variety of other contexts.
Share this story on Facebook

Nasal Inhalation of Oxytocin Improves Face Blindness



Nasal Inhalation of Oxytocin Improves Face Blindness

Sep. 5, 2013 — Prosopagnosia (face blindness) may be temporarily improved following inhalation of the hormone oxytocin.

This is the finding of research led by Dr Sarah Bate and Dr Rachel Bennetts of the Centre for Face Processing Disorders at Bournemouth University that will be presented
today, Friday 6 September, at the British Psychological Society's Joint Cognitive and Developmental annual conference at the University of Reading.

Dr Bate explained: "Prosopagnosia is characterised by a severe impairment in face recognition, whereby a person cannot identify the faces of their family or friends, or even their own face"
The researchers tested twenty adults (10 with prosopagnosia and 10 control participants). Each participant visited the laboratory on two occasions, approximately two weeks apart. On one visit they inhaled the oxytocin nasal spray, and on the other visit they inhaled the placebo spray. The two sprays were prepared by an external pharmaceutical company in identical bottles, and neither the participants nor the researchers knew the identity of the sprays until the data had been analysed.

Regardless of which spray the person inhaled, the testing sessions had an identical format. Participants inhaled the spray, then sat quietly for 45 minutes to allow the spray to take effect. They then participated in two face processing tests: one testing their ability to remember faces and the other testing their ability to match faces of the same identity.

The researchers found that the participants with prosopagnosia achieved higher scores on both face processing tests in the oxytocin condition. Interestingly, no improvement was observed in the control participants, suggesting the hormone may be more effective in those with impaired face recognition systems.

The initial ten participants with prosopagnosia had a developmental form of the condition. Individuals with developmental prosopagnosia have never experienced brain
damage, and this form of face blindness is thought to be very common, affecting one in 50 people. Much more rarely, people can acquire prosopagnosia following a brain injury. At a later date, the researchers had the opportunity to test one person with acquired prosopagnosia, and also observed a large improvement following oxytocin inhalation in this individual.

Dr Bate said: "This study provides the first evidence that oxytocin may be used to temporarily improve face recognition in people with either developmental or acquired prosopagnosia. The effects of the hormone are thought to last 2-3 hours, and it may be that the nasal spray can be used to improve face recognition on a special occasion.
However, much more research needs to be carried out, as we don't currently know whether there are benefits or risks associated with longer-term inhalation of the hormone."
Share this story on Facebook

Wednesday, September 4, 2013

Diabetes-Leptin can replace insulin in future



Diabetes-Leptin  can replace insulin in future
Life Without Insulin Is Possible, Study Suggests

Sep. 3, 2013 — Several millions of people around the world suffer from insulin deficiencies. Insulin is a hormone, secreted by the beta cells in the pancreas, which plays a major role in the regulation of energy substrates such as glucose. This insufficiency, primarily caused by diabetes (types 1 and 2), has lethal consequences if it is not treated. As of now, only daily insulin injections allow patients to survive.This approach, however, brings on serious side effects. Thanks to their research which was published in the journal Cell Metabolism, the University of Geneva (UNIGE) scientists identified the underlying mechanisms, proving that life without insulin is possible, and paving the way for new diabetes treatments.

While life without insulin was inconceivable, a group of researchers, led by Roberto Coppari, professor in the Department of Cell Physiology and Metabolism at UNIGE, has just demonstrated that insulin is not vital for survival. By eliminating this dogma, scientists are now considering alternatives to insulin treatment, which poses many risks to patients. An error in dosage may cause hypoglycemia, i.e., a decrease in the level of glucose in the blood, which can lead to a loss of consciousness. In addition, about 90% of patients over 55 who have been undergoing treatment for several years develop cardiovascular disease due to elevated levels of cholesterol brought on by the lipogenic properties of insulin.

Leptin leads to an essential discoveryResearchers from UNIGE's Faculty of Medicine conducted experiments on rodents devoid of insulin, to which they administered leptin, a hormone that regulates the body's fat reserves and appetite. Thanks to the leptin, all the subjects survived their insulin deficiency. Using leptin offers two advantages: it does not provoke hypoglycemia and it
has a lipolytic effect. 'Through this discovery, the path to offering an alternative to insulin treatment is emerging. Now we need to understand the mechanisms through which leptin affects glucose level, regardless of insulin level,' explains Professor Coppari.

The studies were able to verify whether the neurons involved in the mediation of leptin's anti-diabetic action in healthy mammals played a similar role in rodents suffering from an insulin deficiency. The results showed that this was not the case. In fact, to the scientists' surprise, GABAergic neurons located in the hypothalamus were identified as the main mediators of leptin's action on glucose level in the context of insulin deficiency. These neurons' influence on glucose had never been considered substantial before.

Additionally, the researchers detected the peripheral tissues that are affected by leptin during insulin deficiency. They consist mainly of the liver, the soleus muscle, and brown adipose tissue, which could be directly targeted by future treatments.

Through this discovery, scientists now know where to look for the answer to an insulin-free diabetes treatment. Understanding the functioning and effect of leptin on the body will enable scientists to identify the areas of the body that are involved, and ultimately the molecules that will form the basis of a new treatment.
Share this story on Facebook,

Meaning for mm people
-inconceivable adj
● မယုံၾကည္ႏုိင္ေလာက္ေအာင္။ စိတ္ကူး၍ပင္မရႏုိင္ေသာ။ inconceivably adv မယုံၾကည္ႏုိင္ေလာက္ေအာင္။

-dogma n [C, U]  တရားေသလက္ခံ ထားေသာဝါဒ။